Günay, S.; Parlak, I. S.; Hezer, H.; Şeref Parlak, E. Şengül; Umut, M. S.; Hancıoğlu, Z.; Çelenk Ergüden, H.; Kocaman, Y.; Dalkıran, A.; Sertçelik, Ümran; Şerifoğlu, İrem; Akpınar, E.; Göktaş, M. F.; Fidan, M.; Babahanoğlu, B.; Cander, F. S.; Çıvgın, E.; Er, M.; Kılıç, H.; Argüder, E.; Tuğ, T.; Ünsal, E.; Hasanoğlu, C.; Günay, İrem; Babayiğit, M. .; Ağca, B.; Karalezli, A. Risk Factors for the Development of Interstitial Lung Disease Following Severe COVID-19 Pneumonia and Outcomes of Systemic Corticosteroid Therapy: 3-Month Follow-Up: Interstitial Lung Disease Following Severe COVID-19 Pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2023, 40 (3), e2023029. https://doi.org/10.36141/svdld.v40i3.14418.